Subgingival 0.75% boric acid vs 1% povidone-iodine adjunctive to subgingival instrumentation in stage II and III periodontitis-A double-blind randomized clinical trial

被引:0
|
作者
Pham, Thuy Anh Vu [1 ,2 ]
Nguyen, Minh Duc [1 ,2 ,3 ]
机构
[1] Vietnam Natl Univ, Sch Med, Ho Chi Minh City, Vietnam
[2] Vietnam Natl Univ, Ho Chi Minh City, Vietnam
[3] Hosp Odontostomatol, Ho Chi Minh City, Vietnam
关键词
bacteria; boric acid 0.75%; periodontitis treatment; povidone-iodine 1%; C-REACTIVE PROTEIN; STREPTOCOCCUS-SALIVARIUS; ORAL-CAVITY; BORON; IDENTIFICATION; DISEASE; GROWTH; TIME; IRRIGATION; BACTERIA;
D O I
10.1111/idh.12819
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
PurposeTo compare the effects of subgingival irrigation with 0.75% boric acid (BA) and 1% povidone-iodine (PVP-I) as an adjunct to scaling and root planing (SRP) on clinical and microbiologic parameters in the management of patients with periodontitis after a 12-month follow-up.MethodsSixty systemically healthy individuals diagnosed with periodontitis were included in this double-blind randomised clinical trial. The patients were randomly allocated to treatment groups: (1) SRP plus 0.75% BA and (2) SRP plus 1% PVP-I. Whole-mouth periodontals were clinically examined, and the counts of bacteria including Aggregatibacter actinomycetemcomitans (Aa), Fusobacterium nucleatum (Fn), Porphyromonas gingivalis (Pg), Treponema denticola (Td), Tannerella forsythia (Tf), Solobacterium moorei (Sm) and Streptococcus salivarius (Ss) were tested by real-time polymerase chain reaction (PCR).ResultsAll periodontal parameters and the counts of Aa, Fn, Pg, Td, Tf, Sm and Ss in both groups showed statistically significant reductions at T3, T6 and T12 compared to T0. Whole-mouth or moderate or severe PD and CAL improvements were significantly found in the 0.75% BA group compared to the 1% PVP-I group at T3, T6 and T12. The reduction in Aa or Fn and the reduction in Ss were significantly higher in the 0.75% BA group at T6 and T12 than in the 1% PVP-I group.ConclusionThis study shows that subgingival irrigation with 0.75% BA may be an alternative to 1% PVP-I because it promotes greater PD reductions and CAL gain, particularly up to 12 months after treatment.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 16 条
  • [1] Clinical, microbiological, and immunological effects of 3-or 7-day systemic antibiotics adjunctive to subgingival instrumentation in patients with aggressive (Stage III/IV Grade C) periodontitis: A randomized placebo-controlled clinical trial
    Cosgarea, Raluca
    Jepsen, Soren
    Heumann, Christian
    Batori-Andronescu, Ionela
    Rosu, Alexandra
    Bora, Raluca
    Arweiler, Nicole B.
    Eick, Sigrun
    Sculean, Anton
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2022, 49 (11) : 1106 - 1120
  • [2] Effect of 0.5% povidone-iodine on the nasopharyngeal and oropharyngeal viral loads in patients with COVID-19: A double-blind placebo-controlled randomized clinical trial
    Sharma, Pranav
    Singh, Amit
    Singh, Naresh Pal
    Takhelchangbam, Nilima
    Kumar, Raj
    Yadav, Ramakant
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (10) : 6320 - 6326
  • [3] A Low-Cost Protocol Using the Adjunctive Action of Povidone-Iodine Irrigations and Sodium Hypochlorite Rinsing Solution in Step 2 of Periodontal Therapy for Patients with Stage III-IV Periodontitis: A Single-Blind, Randomized Controlled Trial
    Kardaras, Georgios
    Christodorescu, Ruxandra
    Boariu, Marius
    Rusu, Darian
    Belova, Alla
    Chinnici, Salvatore
    Vela, Octavia
    Radulescu, Viorelia
    Boia, Simina
    Stratul, Stefan-Ioan
    DENTISTRY JOURNAL, 2024, 12 (05)
  • [4] Clinical effectiveness of a topical subgingival application of injectable platelet-rich fibrin as adjunctive therapy to scaling and root planing: a double-blind, split-mouth, randomized, prospective, comparative controlled trial
    Albonni, Hala
    El Abdelah, Ahmad Alaa Al Deen
    Al Hamwi, Mhd Osama Mhd Samer
    Al Hamoui, Wael Bassam
    Sawaf, Hazem
    QUINTESSENCE INTERNATIONAL, 2021, 52 (08): : 676 - 685
  • [5] Evaluating efficacy of a novel dentifrice in reducing probing depths in stage I and II periodontitis maintenance patients: A randomized, double-blind, positive controlled clinical trial
    Kaur, Maninder
    Geurs, Nicolaas C.
    Cobb, Charles M.
    Otomo-Corgel, Joan
    Takesh, Thair
    Lee, June H.
    Lam, Tracie M.
    Lin, Kairong
    Nguyen, Audrey
    Nguyen, Brian L.
    Wilder-Smith, Petra
    JOURNAL OF PERIODONTOLOGY, 2021, 92 (09) : 1286 - 1294
  • [6] SHR-1316 vs placebo in combination with chemotherapy as perioperative treatment in patients with resectable stage II-III NSCLC: A randomized, double-blind, multicenter, phase Ib/III trial
    Wu, Y-L.
    Chen, K.
    Xing, W.
    Chen, Q.
    Liu, L.
    Zhang, Q.
    Ge, D.
    Liu, Y-H.
    Lin, X.
    Wang, L.
    Huang, Y.
    Zhong, W-Z.
    ANNALS OF ONCOLOGY, 2022, 33 : S72 - S72
  • [7] Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.
    Cebon, Jonathan S.
    McArthur, Grant A.
    Chen, Weisan
    Davis, Ian D.
    Gore, Martin Eric
    Thompson, John F.
    Millward, Michael
    Findlay, Michael P. N.
    Dunbar, Rod
    Ottensmeier, Christian H. H.
    Venhaus, Ralph Rudolph
    Nathan, Paul D.
    Dalgleish, Angus George
    Cerundolo, Vincenzo
    Maraskovsky, Eugene
    Hopkins, Wendie
    Marsden, Jeremy
    Smithers, B. Mark
    Hersey, Peter
    Evans, T. R. Jeffry
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Effects of omega-3 fatty acid supplementation on nutritional status and inflammatory response in patients with stage II-III NSCLC undergoing postoperative chemotherapy: a double-blind randomized controlled trial
    Gui, Long
    Cheng, Mingjin
    Zheng, Min
    Ning, Chengdong
    Huo, Qianlun
    FRONTIERS IN NUTRITION, 2023, 10
  • [9] Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study
    Maria Gabriella Grusovin
    Simone Bossini
    Stefano Calza
    Veronica Cappa
    Gianluca Garzetti
    Eleonara Scotti
    Enrico Felice Gherlone
    Magda Mensi
    Clinical Oral Investigations, 2020, 24 : 2015 - 2024
  • [10] Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study
    Grusovin, Maria Gabriella
    Bossini, Simone
    Calza, Stefano
    Cappa, Veronica
    Garzetti, Gianluca
    Scotti, Eleonara
    Gherlone, Enrico Felice
    Mensi, Magda
    CLINICAL ORAL INVESTIGATIONS, 2020, 24 (06) : 2015 - 2024